Engineered pulmonary artery tissues for measuring contractility, drug testing and disease modelling
(2025)
Journal Article
Fellows, A., Quigley, K., Leung, V., Ainscough, A., Wilkins, M., Barnett, H., Miller, D., Mayr, M., & Wojciak-Stothard, B. (2025). Engineered pulmonary artery tissues for measuring contractility, drug testing and disease modelling. British Journal of Pharmacology, https://doi.org/10.1111/bph.17462
Background and PurposeVasoreactivity of pulmonary arteries regulates blood flow through the lungs. Excessive constriction of these vessels contributes to pulmonary arterial hypertension (PAH), a progressive and incurable condition, resulting in right... Read More about Engineered pulmonary artery tissues for measuring contractility, drug testing and disease modelling.